Abstract 4447: Next generation molecular tools for evaluating antibody drug conjugates in 3D systems

Authors

Jayanth S. Shankara Narayanan (ORCID: https://orcid.org/0000-0002-8772-8680)
Ryan W. Holly

Institutions

Thermo Fisher Scientific (United States) (US)

Publication Details

Journal: Cancer Research
Published: 2026-04-03
DOI: https://doi.org/10.1158/1538-7445.am2026-4447
Primary Topic: HER2/EGFR in Cancer Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Abstract 4447: Next generation molecular tools for evaluating antibody drug conjugates in 3D systems

Jayanth S. Shankara Narayanan, Ryan W. Holly

Apr 3, 2026

Cancer Research

HER2/EGFR in Cancer Research

article

Abstract 4447: Next generation molecular tools for evaluating antibody drug conjugates in 3D systems

Jayanth S. Shankara Narayanan, Ryan W. Holly

April 3, 2026article en

Abstract

No abstract available for this paper.

Cancer ResearchVol. 86(7_Supplement)

Thermo Fisher Scientific (United States) (US)

Good health and well-being

Openalex Percentile: Top 10%

HER2/EGFR in Cancer Research

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Abstract 4447: Next generation molecular tools for evaluating antibody drug conjugates in 3D systems — Jayanth S. Shankara Narayanan, Ryan W. Holly · Cancer Research (2026) | TGRS Research Map | TGRS